Skip to main content
. 2014 Jun;6(6):803–809. doi: 10.3978/j.issn.2072-1439.2014.05.02

Figure 2.

Figure 2

Meta-analysis of hazard ratio (HR) of the effect of FGFR1 amplification on survival in patients with non-small cell lung cancer (NSCLC). (A) All six eligible studies; (B) Subgroup of histological subtypes; (C) Subgroup of country of origin; and (D) five FISH evaluated studies. FGFR1, fibroblast growth factor receptor1; FISH, fluorescence in situ hybridization.